HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Feeling Global Squeeze To Adopt Non-Animal Tests, Activists Say

This article was originally published in The Rose Sheet

Executive Summary

China has been pressured to adopt non-animal alternatives for testing cosmetics as the EU marketing ban draws near, more efficacious alternatives arise and Chinese consumers grow more conscious of global concerns, say animal rights activists. Young scientists will likely lead the charge for alternatives in the near term.

You may also be interested in...

Activists Celebrate India’s Expected Ban On Cosmetic Animal Testing

Reportedly, India’s Bureau of Indian Standards has revised its standard for cosmetic safety testing, effectively banning the use of animals to substantiate the safety of cosmetic products and ingredients, in harmony with the European Union. Meanwhile, EU Health Commissioner Tonio Borg reports “first signs of acceptance of alternative methods in China.”

Animal Welfare Group Making “Headway” With Regulators Across Globe

A ban on cosmetic animal testing in Korea “is looking ever more likely,” and Cruelty Free International is making progress in other markets around the world, according to the organization’s Chief Executive Michelle Thew.

PETA Applauds Nature’s Gate For Exiting China’s Cosmetics Market

Nature’s Gate follows the example of brands including Dermalogica and Pangea Naturals, choosing to close its business in China following talks with PETA, which denounces the country’s animal-testing requirements.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts